These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 25667610)

  • 1. Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients.
    Magri V; Marras E; Restelli A; Wagenlehner FM; Perletti G
    Exp Ther Med; 2015 Mar; 9(3):658-666. PubMed ID: 25667610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of infection on the distribution patterns of NIH-Chronic Prostatitis Symptom Index scores in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).
    Magri V; Wagenlehner FM; Marras E; VAN Till JW; Houbiers J; Panagopoulos P; Petrikkos GL; Perletti G
    Exp Ther Med; 2013 Aug; 6(2):503-508. PubMed ID: 24137216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidisciplinary approach to prostatitis.
    Magri V; Boltri M; Cai T; Colombo R; Cuzzocrea S; De Visschere P; Giuberti R; Granatieri CM; Latino MA; Larganà G; Leli C; Maierna G; Marchese V; Massa E; Matteelli A; Montanari E; Morgia G; Naber KG; Papadouli V; Perletti G; Rekleiti N; Russo GI; Sensini A; Stamatiou K; Trinchieri A; Wagenlehner FME
    Arch Ital Urol Androl; 2019 Jan; 90(4):227-248. PubMed ID: 30655633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection.
    Magri V; Trinchieri A; Montanari E; Del Nero A; Mangiarotti B; Zirpoli P; de Eguileor M; Marras E; Ceriani I; Vral A; Perletti G
    Arch Ital Urol Androl; 2007 Jun; 79(2):84-92. PubMed ID: 17695414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study.
    Morgia G; Mucciardi G; Galì A; Madonia M; Marchese F; Di Benedetto A; Romano G; Bonvissuto G; Castelli T; Macchione L; Magno C
    Urol Int; 2010; 84(4):400-6. PubMed ID: 20332612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of influence of the UPOINT-guided multimodal therapy in men with chronic prostatitis/chronic pelvic pain syndrome on dynamic values NIH-CPSI: a prospective, controlled, comparative study.
    Krakhotkin DV; Chernylovskyi VA; Bakurov EE; Sperl J
    Ther Adv Urol; 2019; 11():1756287219857271. PubMed ID: 31263510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flower Pollen Extract in Association with Vitamins (Deprox 500®) Versus Serenoa repens in Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Comparative Analysis of Two Different Treatments.
    Macchione N; Bernardini P; Piacentini I; Mangiarotti B; Del Nero A
    Antiinflamm Antiallergy Agents Med Chem; 2019; 18(2):151-161. PubMed ID: 30488800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of transcutaneous tibial nerve stimulation versus percutaneous tibial nerve stimulation in category IIIB chronic prostatitis/chronic pelvic pain syndrome: A randomized prospective trial.
    Sevim M; Alkiş O; Kartal İG; Kazan HO; İvelik Hİ; Aras B; Kabay Ş
    Prostate; 2023 Jun; 83(8):751-758. PubMed ID: 36871235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erectile Dysfunction in Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Outcomes from a Multi-Center Study and Risk Factor Analysis in a Single Center.
    Zhang Y; Zheng T; Tu X; Chen X; Wang Z; Chen S; Yang Q; Wan Z; Han D; Xiao H; Sun X; Deng C
    PLoS One; 2016; 11(4):e0153054. PubMed ID: 27120096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome.
    Xia D; Wang P; Chen J; Wang S; Jiang H
    Chin Med J (Engl); 2011 Jul; 124(14):2158-61. PubMed ID: 21933619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study.
    Mehik A; Alas P; Nickel JC; Sarpola A; Helström PJ
    Urology; 2003 Sep; 62(3):425-9. PubMed ID: 12946740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
    Magistro G; Wagenlehner FM; Grabe M; Weidner W; Stief CG; Nickel JC
    Eur Urol; 2016 Feb; 69(2):286-97. PubMed ID: 26411805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cernitin pollen extract vs tadalafil therapy for refractory chronic prostatitis/chronic pelvic pain syndrome: A randomized, prospective study.
    Matsukawa Y; Naito Y; Funahashi Y; Ishida S; Fujita T; Tochigi K; Kato M; Gotoh M
    Neurourol Urodyn; 2020 Sep; 39(7):1994-2002. PubMed ID: 32648985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexual dysfunction in type III chronic prostatitis (CP) and chronic pelvic pain syndrome (CPPS) observed in Turkish patients.
    Sönmez NC; Kiremit MC; Güney S; Arisan S; Akça O; Dalkılıç A
    Int Urol Nephrol; 2011 Jun; 43(2):309-14. PubMed ID: 20680450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boswellia resin extract and propolis derived polyphenols in patients with type III chronic prostatitis/chronic pelvic pain syndrome: An Italian prospective multicenter study.
    Presicce F; Barrese F; Cantiani A; Filianoti A; Tuzzolo D; Di Palma P; Lauretti S; Brunori S; Martini M
    Asian J Urol; 2022 Apr; 9(2):139-145. PubMed ID: 35509480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of a monotherapy strategy for difficult chronic prostatitis/chronic pelvic pain syndrome.
    Nickel JC; Downey J; Ardern D; Clark J; Nickel K
    J Urol; 2004 Aug; 172(2):551-4. PubMed ID: 15247727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the UPOINT phenotype system in treating Chinese patients with chronic prostatitis/chronic pelvic pain syndrome: a prospective study.
    Guan X; Zhao C; Ou ZY; Wang L; Zeng F; Qi L; Tang ZY; Dun JG; Liu LF
    Asian J Androl; 2015; 17(1):120-3. PubMed ID: 25248659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracorporeal Shockwave Therapy Combined with Drug Therapy in Chronic Pelvic Pain Syndrome : A Randomized Clinical Trial.
    Rayegani SM; Razzaghi MR; Raeissadat SA; Allameh F; Eliaspour D; Abedi AR; Javadi A; Rahavian AH
    Urol J; 2020 Mar; 17(2):185-191. PubMed ID: 31004340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of nutraceutical medications in men with non bacterial chronic prostatitis and chronic pelvic pain syndrome: A prospective non blinded study utilizing flower pollen extracts versus bioflavonoids.
    Maurizi A; De Luca F; Zanghi A; Manzi E; Leonardo C; Guidotti M; Antonaccio FP; Olivieri V; De Dominicis C
    Arch Ital Urol Androl; 2019 Jan; 90(4):260-264. PubMed ID: 30655636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-year experience with the german-translated version of the NIH-CPSI in patients with CP/CPPS.
    Schneider H; Brähler E; Ludwig M; Hochreiter W; Collins MF; Eremenco S; Weidner W
    Urology; 2004 Jun; 63(6):1027-30. PubMed ID: 15183940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.